Consistent with this study, other studies have shown that adding CCL20 to existing NPC screening assays can increase the efficiency of initial screening and that high levels of serum CCL20 may indicate a poor NPC prognosis (8, 58). This evidence concerns the gene CCL20 and nasopharyngeal carcinoma.